蚌埠医学院学报
蚌埠醫學院學報
방부의학원학보
ACTA ACADEMIAE MEDICINAE BENGBU
2014年
9期
1187-1189
,共3页
感染%化脓性%骨与关节%耐药性%病原菌
感染%化膿性%骨與關節%耐藥性%病原菌
감염%화농성%골여관절%내약성%병원균
infection%purulency%bone and joints%drug resistance%pathogen
目的：评估骨与关节化脓性感染的主要病原菌分布及其抗菌谱变化情况,为临床抗菌药物治疗提供参考依据。方法：分析骨与关节化脓性感染患者的418份各类标本中分离出的病原菌,进行菌种鉴定和药敏试验。结果：418份送检标本中共分离出388株病原菌,其中G+球菌212株,G-杆菌176株。金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌、奇异变形菌和表皮葡萄球菌的检出率最高,分别为38.28%、11.48%、8.13%、5.26%和4.78%。结论：耐药的金黄色葡萄球菌是骨与关节化脓性感染的主要致病菌,治疗应依据药敏试验结果实施个体化的抗生素治疗方案,降低细菌耐药性的发生。
目的：評估骨與關節化膿性感染的主要病原菌分佈及其抗菌譜變化情況,為臨床抗菌藥物治療提供參攷依據。方法：分析骨與關節化膿性感染患者的418份各類標本中分離齣的病原菌,進行菌種鑒定和藥敏試驗。結果：418份送檢標本中共分離齣388株病原菌,其中G+毬菌212株,G-桿菌176株。金黃色葡萄毬菌、銅綠假單胞菌、大腸埃希菌、奇異變形菌和錶皮葡萄毬菌的檢齣率最高,分彆為38.28%、11.48%、8.13%、5.26%和4.78%。結論：耐藥的金黃色葡萄毬菌是骨與關節化膿性感染的主要緻病菌,治療應依據藥敏試驗結果實施箇體化的抗生素治療方案,降低細菌耐藥性的髮生。
목적：평고골여관절화농성감염적주요병원균분포급기항균보변화정황,위림상항균약물치료제공삼고의거。방법：분석골여관절화농성감염환자적418빈각류표본중분리출적병원균,진행균충감정화약민시험。결과：418빈송검표본중공분리출388주병원균,기중G+구균212주,G-간균176주。금황색포도구균、동록가단포균、대장애희균、기이변형균화표피포도구균적검출솔최고,분별위38.28%、11.48%、8.13%、5.26%화4.78%。결론：내약적금황색포도구균시골여관절화농성감염적주요치병균,치료응의거약민시험결과실시개체화적항생소치료방안,강저세균내약성적발생。
Objective:To explore the pathogenic bacteria distribution of bone and joint purulent infection and its drug resistance for providing the basis of antimicrobial treatment. Methods:The pathogenic bacteria from 418 samples of patients with bone and joint purulent infection were isolated and identified, and the antibiotics sensitivity tests were examined. Results:Two hundred and twelve strains gram-positive bacteria and 176 gram-negative bacteria were isolated form 418 samples. The detection rates of Staphylococcus aureus,Pseudomon asaeruginosa,Escherichia coli,Proteus mirabilis and Staphylococcus epidermidis were 38. 28%,11. 48%,8. 13%, 5. 26% and 4. 78%,respectively. Conclusions:The drug-resistant Staphylococcus aureus is the mainly pathogenic bacteria of bone and joint purulent infection. The antibiotics treatment should be taken according to the results of antibiotics sensitivity tests which can induce the resistance to antibiotics.
